AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • October 7th, 2019 • Ocugen, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledOctober 7th, 2019 Company Industry JurisdictionThis AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT (this “Amendment”), is made and entered into as of October 4, 2019, between Medavate Corp., a Colorado corporation (“Buyer”) and Ocugen, Inc., a Delaware corporation formerly known as Histogenics Corporation (“Seller”). Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in that certain Asset Purchase Agreement dated as of May 8, 2019 between Buyer and Seller, as amended by that certain Amendment No. 1 to Asset Purchase Agreement dated September 26, 2019 (collectively, the “Asset Purchase Agreement”).